SCHEMBL13617663

SCHEMBL13617663

BC[C@H](O)c1ccc(OCCCC)c2[nH]c(=O)ccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 19/20 0.44
DRD2 P14416 3/20 0.44
DRD3 P35462 3/20 0.44
DRD1 P21728 2/20 0.44
DRD4 P21917 2/20 0.44
ADRB1 P08588 9/20 0.44
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
PTGS2 P35354 1/20 0.41
KMT2A Q03164 1/20 0.41
SLC6A2 P23975 1/20 0.41
ADRA1D P25100 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13617868 0.91 ADRB2 (0.47) ADRB2DRD2DRD3DRD1DRD4
SCHEMBL15630202 0.90 ADRB2 (0.43) ADRB2DRD2DRD3DRD1DRD4
SCHEMBL13697685 0.89 ADRB2 (0.42) ADRB2DRD2DRD3DRD1DRD4
SCHEMBL18601883 0.89 ADRB2 (0.42) ADRB2DRD2DRD3DRD1DRD4
SCHEMBL16066905 0.89 ADRB2 (0.42) ADRB2DRD2DRD3DRD1DRD4
SCHEMBL16066898 0.80 ADRB2 (0.72) ADRB2DRD2DRD3DRD1DRD4
SCHEMBL13617485 0.80 ADRB2 (0.59) ADRB2DRD2DRD3DRD1DRD4
SCHEMBL13868998 0.80 ADRB2 (0.72) ADRB2DRD2DRD3DRD1DRD4
SCHEMBL18993729 0.80 ADRB2 (0.49) ADRB2DRD2DRD3DRD1DRD4
SCHEMBL13617477 0.79 ADRB2 (0.37) ADRB2DRD2DRD3DRD1DRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1641465-B1 COMBINATIONS OF AN ARYL ANILINE BETA-2 ADRENERGIC RECEPTOR AGONIST AND A CORTICOSTEROID THERAVANCE INC (US) 2009-11-04 EP disclosed
US-7582765-B2 Aryl aniline β2 adrenergic receptor agonists THERAVANCE, INC. (US) 2009-09-01 US disclosed
US-7553971-B2 Aryl aniline β2 adrenergic receptor agonists THERAVANCE, INC. (US) 2009-06-30 US disclosed